skip to main content

Liothyronine prescribing governance — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateEndocrine TherapeuticsLiothyronine prescribing governanceGPhC CRA

A private clinic prescription requests liothyronine for a patient with persistent tiredness despite normal thyroid function tests. The patient asks the community pharmacy to dispense it immediately. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — Check clinical appropriateness and local governance before supply, and liaise with the prescriber if concerns remain

Liothyronine is not banned, but its use is subject to careful specialist consideration and local prescribing governance. A pharmacist must still assess clinical appropriateness and prescription validity, including private prescriptions. Therapeutic substitution is not appropriate without prescriber involvement. Normal thyroid function tests and non-specific symptoms warrant careful review.

Reference: BNF; NHS England prescribing guidance